A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma.
- DOI
- 10.1016/j.actbio.2026.07.023
- Published
- 2026 Sep
- Container
- Acta biomaterialia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.actbio.2026.07.023,
title = {A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma.},
author = {Qiu F and Hu H and Li K and Qi H and Liu P and Zou T and Gong P and Weng Q and Shen L and Zheng L and Fang S and Chen M and Shu G and Tu J and Ji J},
year = {2026},
journal = {Acta biomaterialia},
doi = {10.1016/j.actbio.2026.07.023},
url = {https://doi.org/10.1016/j.actbio.2026.07.023}
}RIS
TY - JOUR TI - A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma. AU - Qiu F AU - Hu H AU - Li K AU - Qi H AU - Liu P AU - Zou T AU - Gong P AU - Weng Q AU - Shen L AU - Zheng L AU - Fang S AU - Chen M AU - Shu G AU - Tu J AU - Ji J PY - 2026 JO - Acta biomaterialia DO - 10.1016/j.actbio.2026.07.023 UR - https://doi.org/10.1016/j.actbio.2026.07.023 ER -
APA
F, Q., H, H., K, L., H, Q., P, L., T, Z., P, G., Q, W., L, S., L, Z., S, F., M, C., G, S., J, T., & J, J. (2026). A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma.. Acta biomaterialia. https://doi.org/10.1016/j.actbio.2026.07.023
Source records
- pubmed · retrieved 2026-09-26T13:29:01.103Z